Based on the Abivax SA stock forecast from 0 analysts, the average analyst target price for Abivax SA is not available over the next 12 months. Abivax SA’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Abivax SA is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Abivax SA’s stock price was EUR 7.06. Abivax SA’s stock price has changed by -1.12% over the past week, -14.22% over the past month and -28.40% over the last year.
No recent analyst target price found for Abivax SA
No recent average analyst rating found for Abivax SA
Frequently Asked Questions About Abivax SA (ABVX:PA) Stock
Stock Target Advisor's fundamental analysis for Abivax SA's stock is Bearish.
Unfortunately we do not have enough data on ABVX:PA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ABVX:PA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ABVX:PA's stock to indicate if its overvalued.
The last closing price of ABVX:PA's stock was EUR 7.06.
The most recent market capitalization for ABVX:PA is EUR 0.49B.
Unfortunately we do not have enough analyst data on ABVX:PA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Abivax SA's stock.
As per our most recent records Abivax SA has 62 Employees.
Abivax SA's registered address is 7-11 boulevard Haussmann, Paris, France, 75009.
You can get more information about it from Abivax SA's website at https://www.abivax.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Abivax SA (ABVX:PA) Stock
Stock Target Advisor's fundamental analysis for Abivax SA's stock is Bearish.
Unfortunately we do not have enough data on ABVX:PA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ABVX:PA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ABVX:PA's stock to indicate if its overvalued.
The last closing price of ABVX:PA's stock was EUR 7.06.
The most recent market capitalization for ABVX:PA is EUR 0.49B.
Unfortunately we do not have enough analyst data on ABVX:PA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Abivax SA's stock.
As per our most recent records Abivax SA has 62 Employees.
Abivax SA's registered address is 7-11 boulevard Haussmann, Paris, France, 75009.
You can get more information about it from Abivax SA's website at https://www.abivax.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ABVX:PA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
